Prostate Cancer Screening

I. Trends in Prostate Cancer Screening

1. Overview of US Prostate Cancer Trends in the Era of PSA Screening
Ruth Etzioni, Roman Gulati, Angela Mariotto

2. Trends in Prostate Cancer Screening: Overview of the UK
Richard J. Bryant, Freddie C. Hamdy

3. Trends in Prostate Cancer Screening: Canada
Robert K. Nam, Laurence H. Klotz

4. Trends in Prostate Cancer Screening – Overview of Europe
Sanjai K. Addla, Bob Djavan

II. Prostate-Specific Antigen

5. Evolution of Prostate-Specific Antigen for Screening
Javier Hernandez, Edith Canby-Hagino

6. The Performance Characteristics of Prostate-Specific Antigen for Prostate Cancer Screening
Ian M. Thompson, Donna P. Ankerst

7. The Performance of PSA for Predicting Prostate Cancer After a Prior Negative Prostate Biopsy
Catherine M. Tangen

8. Subfractions and Derivatives of Total Prostate-Specific Antigen in the Early Detection of Prostate Cancer
Alexander Haese, Alan W. Partin

9. PSA Velocity at Presentation as a Predictor of Prostate Cancer Aggressiveness
Jason A. Efstathiou, Anthony V. D’Amico

III. Risk Assessment for Prostate Cancer

10. Nomograms for Prostate Cancer
Shahrokh F. Shariat, Michael W. Kattan

11. Decision Aid Criteria and Artificial Neural Networks for Optimizing Prostate Cancer Risk Prediction
Felix K.-H. Chun, Pierre I. Karakiewicz

12. Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator
Donna P. Ankerst, Ian M. Thompson

13. Integration of Risk Assessment in Prostate Cancer Screening
Kadee E Thompson, Amanda Reed, Dipen J Parekh

14. Family History of Prostate Cancer During Rapidly Increasing Incidence
Kari Hemminki, Justo Lorenzo Bermejo

IV. Recent Biomarkers for Prostate Cancer

15. PSA Isoforms: [-2]proPSA Significant Adjunct to Free PSA
Jeffrey E. Tam

16. PCA3
Jack Groskopf, Jack Schalken, Harry Rittenhouse

17. Transcriptional Profiling of Prostate Cancer: Biomarker Identification and Clinical Applications
Nigel Clegg, Peter S. Nelson

18. Biomarkers for Prostate Cancer Detection: Family-Based Linkage Analysis and Case–Control Association Studies
Joke Beuten, Teresa L Johnson-Pais

19.
GSTP1 Hypermethylation for Prostate Cancer Detection
Rui Henrique, Carmen Jerónimo

20. EPCA and EPCA-2 as Potential Biomarkers for Prostate Cancer Detection
Eddy S. Leman, Robert H. Getzenberg

V. Design and Methodologic Considerations in Biomarker Studies

21. Toward a Robust System for Biomarker Triage and Validation – EDRN Experience
Ziding Feng, Jacob Kagan, Sudhir Srivastava

22. Statistical Evaluation of Markers and Risk Tools for Prostate Cancer Classification and Prediction
Yingye Zheng, Donna P. Ankerst

23. Pitfalls in Prostate Cancer Biomarker Evaluation Studies
Donna P. Ankerst

VI. Building upon Recently Completed and Ongoing Prospective Trials

24. Prostate-Specific Antigen and Its Role on the Prostate Cancer Prevention Trial
Catherine M. Tangen, Phyllis J. Goodman

25. The Selenium and Vitamin E Cancer Prevention Trial
Eric A. Klein

26. PLCO: A Randomized Controlled Screening Trial for Prostate, Lung, Colorectal, and Ovarian Cancer
Amanda Black, Robert L. Grubb, E David Crawford

27. The European Randomized Study of Screening for Prostate Cancer (ERSPC)
Tineke Wolters, Fritz H. Schröder

Avainsanat: MEDICAL / Public Health MED078000